- Titre
- Long-Term Efficacy and Safety of the Microsomal Triglyceride Transfer Protein Inhibitor Lomitapide in Patients With Homozygous Familial Hypercholesterolemia
- Créateurs - sans rôle
- Dirk Blom - University of Cape TownMaurizio Averna - Università degli studi di Palermo - University of PalermoEmma Meagher - University of PennsylvaniaHendrik Du Toit TheronCesare SirtoriRobert Hegele - Western UniversityPrediman Shah - Cedars-Sinai Medical CenterDaniel Gaudet - Université du Québec à MontréalClaudia Stefanutti - Sapienza University of RomeGiovanni Vigna - University of FerraraDominique Larrey - Institute for Regenerative Medicine & BiotherapyLeanne BloedonPamela FouldsDaniel Rader - University of PennsylvaniaMarina Cuchel - University of Pennsylvania
- Détails de publication
- Circulation, Vol.136(3), pp.332 - 335
- Identifiants
- 99161043009311
- Unité académique
- Cell souches plasticité cellul régénérat tissulaire immuno des maladies inflamm - IRMB
- Langue
- English
- Type de ressource
- Journal article
- Champs locaux
- hal-01758400
Article de revue
Long-Term Efficacy and Safety of the Microsomal Triglyceride Transfer Protein Inhibitor Lomitapide in Patients With Homozygous Familial Hypercholesterolemia
Circulation, Vol.136(3), pp.332 - 335
18/07/2017
PMID: 28716835
Indicateurs
1 Consultations de la notice